Pulmonary and Cardiovascular Consequences of Inhaled Nicotine (R01)

 

The purpose of this funding opportunity announcement (FOA) is to stimulate mechanistic research on the pathophysiological effects of inhaled nicotine on the respiratory and cardiovascular systems in the context of non-cancer heart and lung diseases. This FOA invites applications that will investigate effects of nicotine exposure using cellular systems, animal models, and/or humans. Projects must include experiments at the molecular/cellular level as well as experiments at the tissue/organ/whole animal level. Applications should address hypotheses mechanistically linking nicotine-responsive molecular and cellular pathways with clinically relevant outcomes.

Active RFA-HL-17-008 Agency: Department of Health and Human Services
Office: National Institutes of Health Grant 6 Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. 05/07/2016 This program does not have cost sharing or matching requirements. NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-17-008.html FBOWebmaster@OD.NIH.GOV $2,880,000.00 Awards up to $300,000.00